Sign In
Buy CYCC
$6.37
+0 (+0%)
At Close: Dec 10, 2025
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2020 in San Francisco
12:00pm, Monday, 06'th Jan 2020
Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announces that the
Introducing Cyclacel Pharmaceuticals (NASDAQ:CYCC), The Stock That Tanked 92%
11:13am, Wednesday, 11'th Dec 2019
This month, we saw the Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) up an impressive 99%. But that doesn't change the...
BERKELEY HEIGHTS, N.J., Dec. 09, 2019 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing.
38 Healthcare Stocks Moving In Monday's Pre-Market Session
12:00am, Monday, 09'th Dec 2019Edited Transcript of CYCC earnings conference call or presentation 13-Nov-19 9:30pm GMT
12:18pm, Wednesday, 04'th Dec 2019
Q3 2019 Cyclacel Pharmaceuticals Inc Earnings Call
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
12:00am, Sunday, 01'st Dec 2019Cyclacel Pharmaceuticals Reports Third Quarter 2019 Financial Results
09:05pm, Wednesday, 13'th Nov 2019
– Investigator-Reported Partial Response in Phase 1 Study of CYC065 as Single Agent – – Conference Call Scheduled November 13, 2019 at 4:30 p.m. ET – BERKELEY HEIGHTS, N.J.,.
